Prmt1-mediated methylation of Ddx17 promotes osteoblast differentiation via regulating the alternative splicing of Sh2b1
Bone · 2026
DOI: 10.1016/j.bone.2026.117798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2026. Verfasst von Xinluan Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Longmian Road 101, Nanjing, PR China. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Osteoblasts, Cell Differentiation, Alternative Splicing. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteoporosis (OP) is characterized by impaired osteoblast-mediated bone formation and reduced mineralization, which increases fracture risk and challenges global skeletal health. Ddx17 (DEAD-box helicase 17) is implicated in multiple cancers, but its role and mechanism in bone biology, especially in osteoblast differentiation and osteoporosis pathogenesis remain unclear. In this study, we demonstrated that Ddx17 expression was significantly reduced in trabecular bones of patients with osteoporosis. During osteoblastic differentiation of MC3T3-E1 and C3H10T1/2 cells, Ddx17 expression levels increased gradually in a time-dependent manner. Loss-of-function and gain-of-function experiments revealed that Ddx17 promoted osteoblast proliferation and differentiation. Mechanistically, Ddx17 was a direct substrate of Prmt1 (protein arginine methyltransferase 1), which specifically catalyzed ADMA modification of Ddx17 at R426, thereby enhancing Ddx17 protein stability. Stabilized Ddx17 modulated the alternative splicing of Sh2b1 mRNA, thereby promoting the expression of Sh2b1-T1 while suppressing that of Sh2b1-T2. Rescue experiments demonstrated that re-expression of Sh2b1-T1, but not Sh2b1-T2, reversed the impairment of osteoblast differentiation triggered by Ddx17 knockdown. Taken together, these findings underscore the critical role of the Prmt1-Ddx17-Sh2b1 axis in regulating osteoblast differentiation and suggest this axis as a promising therapeutic target for osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Longmian Road 101, Nanjing, PR China.
- Department of Orthopedics, BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, PR China. Electronic address: huimin.ding@benqhospital.com.
- Department of Medical Genetics, School of Basic Medical Sciences, Nanjing Medical University, Longmian Road 101, Nanjing, PR China. Electronic address: cyma@njmu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Jiang, X., Li, B., Ma, Y., Huang, J., Gu, C., Jin, Y., Ding, H., & Ma, C. (2026). Prmt1-mediated methylation of Ddx17 promotes osteoblast differentiation via regulating the alternative splicing of Sh2b1. Bone. https://doi.org/10.1016/j.bone.2026.117798
Vancouver
Jiang X, Li B, Ma Y, Huang J, Gu C, Jin Y, et al. Prmt1-mediated methylation of Ddx17 promotes osteoblast differentiation via regulating the alternative splicing of Sh2b1. Bone. 2026. doi:10.1016/j.bone.2026.117798
BibTeX
@article{Jiang2026,
author = {Jiang, Xinluan and Li, Bilan and Ma, Yunfei and Huang, Jiaxin and Gu, Chengwei and Jin, Yucui and Ding, Huimin and Ma, Changyan},
title = {Prmt1-mediated methylation of Ddx17 promotes osteoblast differentiation via regulating the alternative splicing of Sh2b1},
journal = {Bone},
year = {2026},
doi = {10.1016/j.bone.2026.117798}
}
EUVIMED